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Abstract 
Purpose: To evaluate the opinions of community pharmacists on the usefulness and reliability of drug 
package inserts (DPI) as drug information source, and necessary modifications needed to improve their 
contents.  
Methods: A prospective cross-sectional study using a pretested questionnaire was administered to 
sixty-one superintendent community pharmacists (CP) across two cities in southwestern Nigeria. 
Descriptive statistics was used to summarize the data and evaluate respondents’ opinion. Kruskal-
Wallis test was used to evaluate the rank variables with p < 0.05 considered significant. 
Results: A majority of CP believed that information from DPI was precise and may be helpful in 
achieving therapeutic success (n = 42; 72.8 %). CP believed there is need for the modification of DPI 
content with respect to patient-related information (n = 52; 92.8 %) and health provider-related 
information (n = 52; 94.5%), non-uniformity of information on the same generic medicines (n = 31; 50.8 
%), and ambiguity of content (n = 29; 47.5 %). Years of experience in practice significantly influenced 
respondents’ perception of precision and satisfaction with DPI as source of information. 
Conclusions: Community pharmacists in southwestern Nigeria believed that a properly modified drug 
package insert could be a useful and reliable source of drug information in daily practice.  
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Demand for drug information by health care 
professionals and patients underscores the need 
for a reliable, easily accessible and non-
expensive source of information that will aid 
informed therapeutic decision in the 
management of diseases. Sources of drug 
information are numerous and are useful in 
situations where there is immediate need to 
counsel patients, choose dosage or check for 
contraindications. Healthcare professionals make 
use of different types of drug information sources 
including primary, secondary and tertiary 
sources, each with its areas of strength and 
weakness [1-3].  
 
In resource-limited settings, drug package inserts 
(DPI) are probably the most readily available 
source of drug information since it always 
accompanies prescription and non-prescription 
medicines. Information from DPI may sometimes 
not be up-to-date, and inconsistent when 
compared with other sources of drug information 
[1-4]. Although written drug information may 
sometimes cause fear of possible adverse 
effects, DPI may also be useful in increasing 
patient’s knowledge, compliance and satisfaction 
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as well as enable patients have access to 
information about their medications [5,6]. Thus, 
DPI could be a source of information in 
developing and developed countries wherever 
drug information is needed.  
 
Information obtainable in DPI for the same 
generic medications by different manufacturers 
are often inconsistent and sometimes conflicting 
[7-9]. Also, some consumers find the language 
difficult to comprehend and find it more complex 
than what is commensurate with an individual’s 
literacy level [10].  
 
The source of drug information is important 
especially in developing nations such as Nigeria 
where strict medicine regulation is sometimes 
lacking. Such countries are at a distinct 
disadvantage if the practitioners cannot source 
reliable independent information about 
medicines.  The present study therefore seeks to 
evaluate and assess the opinions of community 
pharmacists in southwestern Nigeria on the 
usefulness, adequacy, reliability and level of 
satisfaction with DPI as a veritable source of 
drug information in daily practice. Opinions of 
respondents on necessary modifications to make 
DPI a reliable tool for obtaining drug information 




Study design and population  
 
This prospective cross-sectional study was 
carried out among licensed community 
pharmacists (CP) in two state capital cities 
(Ibadan and Oshogbo) in southwestern Nigeria 
using a pre-tested structured questionnaire. At 
the time of the study in March 2010, 93 premises 
were registered in the two states with the 
Pharmacists Council of Nigeria (PCN), the official 
regulatory body of pharmacy profession and 
education in Nigeria. Included in the study were 
CPs who were superintendent pharmacists in 
charge of registered pharmacies in the two cities. 
Only pharmacies licensed for the year of study, 
and who had pharmacists in residence with not 
less than one-year post full PCN-registration 
experience were enrolled in the study. 
 
Based on the number of registered community 
pharmacists at the time of study at a 5 % margin 
of error, a sample size of 76 was obtained using 
the Raosoft(R) Sample size calculator [11].  
 
CPs were identified using PCN directory of 
licensed pharmacists for the year of study. The 
CPs were then visited in their respective 
pharmacies and administered the questionnaire. 
CPs who were not in their premises at the time of 
visitation were excluded. No two CPs were taken 
from the same pharmacy. Eighty questionnaires 
were administered within the study period in the 
two cities comprising 59 (73.8%) questionnaires 
in Ibadan and 21 (26.2%) in Oshogbo. 
 
Pretest and questionnaire construction 
 
The questionnaire was pretested among three 
pharmacists in academia for content validity. 
Based on the feedback from the validity 
assessments, some modifications were made to 
the question format including the replacement of 
dichotomous “YES/NO” response options with 
likert scale of five graded response (strongly 
disagree – 1, disagree – 2, neutral – 3, agree – 4 
and strongly agree – 5). Also, ambiguous 
questions were rephrased to convey clear 
intentions.  
 
Section A obtained information on the 
demographic characteristics of respondents 
while section B obtained the opinions of 
respondents on sources of drug information in 
daily practice, perceptions on the use of DPI as 
source of drug information, level of satisfaction 
with the information obtainable from drug 
package inserts, and opinion on the probable 
modifications that will make the DPI a reliable 
source of drug information. The questionnaires 
which took between 25 and 30 min to complete 
were administered to respondents in their places 
of practice by the investigators.  
 
Out of the 80 questionnaires administered, 61 
(76.3 %) questionnaires were properly completed 
and found fit for analysis. The remaining 19 
questionnaires were either incompletely filled or 




The data obtained was subjected to analysis 
using the Statistical Package for the Social 
Sciences (SPSS) version 17.0. Descriptive 
statistics were used to summarize the data with 
median value (50 percentile) used in describing 
respondents’ opinion to particular statements in 
ordinal scale.  Kruskal Wallis test was used to 
evaluate the association between years of 
experience in community practice and 
respondents’ opinions in ordinal variables. The 
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The response rate was 76.3 %. There were 12 
(19.7 %) respondents with age range of 21 - 30 
years, 31 - 40 years (n = 23, 37.7 %), 41-50 
years (n = 8, 13.1%), while 18 (29.5%) were 
aged > 50 years. Thirty one respondents (50.8%) 
had been in practice as community pharmacists 
for 1-10 years; nine (14.8%) for 11- 20 years, 
while 21 (34.4 %) had been in practice for > 20 
years. 
 
Sixty (98.4 %) respondents made use of drug 
package inserts in their places of practice, 
although all the respondents used more than one 
source of drug information. Other sources of drug 
information used by respondents in different 
combinations included the Essential Drug List 
(EDL, n = 48, 78.7 %), reference books such as 
British Pharmaceutical Codex and British 
National Formulary (n = 38, 62.3 %), peer-
reviewed pharmacy journals (n = 38, 62.3 %), 
Internet-based websites (n = 37, 60.7 %), 
textbooks (n = 33, 54.1 %), peer-reviewed 
medical and therapeutic journals (n = 32, 52.5 
%), and encyclopedia (n = 16, 26.2 %). Drug 
Information Centers (DICs) were consulted by 
nine (14.8%) of the respondents.  Of the sixty 
(98.4%) respondents who use DPI; side effects 
(n = 48, 78.7 %) were the most often sought 
information from DPI followed by contraindication 
(n = 46, 75.4 %), drug interaction (n = 42, 73.8 
%), and drug dosing (n = 41, 67.2 %) in different 
combinations. However, respondents cited the 
most common obtainable information from DPI to 
include side effects (n = 40, 65.6 %), 
contraindication (n = 32, 52.5 %), while drug 
dosing and general product information was 
reported by 35 respondents (57.4 %) each. 
These responses were cited in combinations.  
The most frequently omitted information from DPI 
included teratogenicity (n = 21, 34.4 %), and 
pharmaceutical incompatibility (n = 16, 26.2 %). 
Details of respondents’ opinion on the most often 
sought information and those that were 
commonly obtainable are shown in Table 1.  
 
Fifty three (86.9 %) respondents were usually 
consulted by patients for clarification on 
information from DPI, while 52 (85.2 %) referred 
their patients to relevant information in DPI as a 
follow-up to the counseling on dispensed or 
recommended medications.  Fifty two (85.2 %) 
respondents believed that DPI has great 
educative potentials. Other details of 
respondents’ opinions on information to which 
DPI are most appropriate are shown in Table 2.  
 
Parameters that were significantly influenced by 
the length of experience in practice included 
opinion on whether manufacturer’s information in 
DPI is accurate (p=0.007), and whether 
information from DPI is helpful in achieving 
therapeutic success (p=0.047) (Table 3). 
Respondents with years of experience above 20 
had the highest mean rank (36.35) suggesting 
that they were the ones who largely agreed that 
the manufacturer’s information in DPI is 
accurate.  The effect of length of experience in 
practice on the opinion of CP on accuracy and 
frequency of use of information of DPI is shown 
in Table 3. 
 
 
Table 1:  Summary of respondents’ opinions on the most often sought and obtainable information from 
drug package inserts (DPI) 
 
Respondents’ opinion N (%)*  
Variable Most often sought 
information from DPI 
Common obtainable 
information from DPI 
Side effects/Adverse reactions 48 (78.7) 40 (65.6) 
Contraindication 46 (75.4) 32 (52.5) 
Drug interaction 42 (68.9) 25 (41.0) 
Drug dosing 41 (67.2) 35 (57.4) 
General product information 35 (57.4) 35 (57.4) 
Therapeutic efficacy 32 (52.5) 27 (44.3) 
Dosing time 28 (45.9) 20 (32.8) 
Toxicity 27 (44.3) 17 (27.9) 
Teratogenicity 25 (41.0) 15 (24.6) 
Pharmaceutical compatibility 16 (26.2) 12 (19.7) 
Pharmaceutical identification 15 (24.6) 17 (27.9) 
Drug formulation 12 (19.7) 17 (27.9) 
Drug choice availability 10 (16.4) 13 (21.3) 
* - Responses are in different combinations 
DPI – Drug Package Inserts 
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Table 2:   Respondents’ opinions (in ranks) on adequacy and frequency of use of information from DPI 
 
Respondents’ opinion   N (%) Variable 





Frequency of patient’s consult for 
clarification of  information from 
DPI (N=60) 
2 (3.3) 16 (26.7) 29 (48.3) 11(18.3) 2 (3.3) 3 0.168 
Frequency of patient’s referral to 
information supplied in DPI for  
follow-up drug usage  
(N=61) 
8 (13.1) 12 (19.7) 28 (45.9) 11 (18.0) 2 (3.3) 3 0.209 
Educative potential of DPI 
information (N=56) 
0 (0.0) 4 (7.1) 24 (42.9) 25 (44.6) 3 (5.4) 3 0.528 
 
Appropriateness of information 
from DPI with respect to: 
       
Drug interaction (N=57) 4(7.0) 24(42.1) 13(22.8) 11(19.3) 5 (8.8) 3 0.957 
Dosage (N=57) 2 (3.5) 0 (0.0) 9(15.8) 25(43.9) 21(36.8) 4 0.445 
Dosing time (N=56) 1 (1.8) 7(12.5) 16(28.6) 20(35.7) 12(21.4) 4 0.494 
Duration of action (N=57) 2 (3.5) 8 (14.0) 20(35.1) 19(33.3) 8(14.0) 3 0.974 
Side effect (N=56) 0 (0.0) 1 (1.8) 14 (25.0) 25(44.6) 16(28.6) 4 0.626 
Toxicity (N=54) 5 (9.3) 23(42.6) 15(27.8) 7(13.0) 4(7.4) 2 0.328 
Over-the-counter medicine 7(13.5) 25(48.1) 16(30.8) 3(5.8) 1(1.9) 2 0.964 
*K-W - Kruskal Wallis test for respondents’ years of experience in practice as community pharmacist; Never = 1, Rarely = 2, 
Sometimes = 3, Often = 4, Always = 5, DPI = Drug package inserts, N = Number 
 
Table 3:  Distribution of respondents’ opinion on precision and satisfaction about the information from 
DPI 
 
Respondents’ opinions N (%) Variable 





Manufacturer’s information in 
DPI is accurate (N =58) 
0 (0.0) 10 
(17.2) 
11(19.0) 33(56.9) 4(6.9) 4 0.007* 
Information from DPI is helpful  
in achieving therapeutic 
success ( N=58) 
2 (3.4) 4(6.9) 10(17.2) 32(55.2) 10(17.2) 4 0.047* 
Information in DPI that needs 
modification with respect to:  
       
Patient-related information 
(N=56) 
3(5.4) 0(0.0) 1 (1.8) 32(57.1) 20(35.7) 4 0.898 
Healthcare professional-related 
information (N=55) 
1 (1.8) 0 (0.0) 2(3.6) 34(61.8) 18(32.7) 4 0.244 
Easy understanding by lay 
patient (N=54) 
3 (5.6) 2 (3.7) 3 (5.6) 27(50.0) 19(35.2) 4 0.796 
*Significant difference with Kruskal-Wallis (K-W) test for respondents’ years of experience in practice as community pharmacist; 
SD (strongly disagree) = 1, D (Disagree) = 2, N (Neutral) = 3, A (Agree) = 4, SA (Strongly agree) = 5, DPI = Drug package 
inserts, N = Number 
 
Fifty two (92.9 %) respondents believed there is 
a need for modification of information in DPI in 
respect of patient-related information, and 
healthcare professional-related information (n = 
52, 94.5 %), as shown in Table 3. Forty-six (75.4 
%) believed that modifications of information in 
DPI should include, in different combinations, 
typography (n = 16, 26.2 %), uniformity of 
information on the same generic with different 
proprietary names (n = 31, 50.8 %), language (n 
= 22, 36.1 %), and clarity of contents (n = 29, 
47.5 %) so as to ensure easy comprehension by 
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Regardless of the years of experience or age or 
sex of respondents, almost all the community 
pharmacists who participated in the study relied 
on drug package inserts either alone or in 
combination with other drug information sources 
including primary, secondary and a few tertiary 
sources. The use of DPI is not limited to 
developing countries such as Nigeria alone. A 
study in Sweden showed that most community 
pharmacists use DPI and standard reference 
books as sources of drug information especially 
for drug indication and adverse drug effects [12].  
The findings of this study indicated that 
information most readily obtainable from DPI are 
side effects or adverse reactions which is 
probably the most important information required 
to guide  patients on commonly encountered 
drug use problems, while information on toxicity, 
teratogenicity, drug interaction, pharmaceutical 
incompatibilities, and pharmaceutical product 
identification were not always obtainable.  
 
A study carried out in Saudi Arabia reported that 
majority of the patients who use DPI always look 
for information on drug indication and adverse 
drug effects which were not always available [9]. 
Though it has been reported that information on 
side effects from DPI, if accessed by patients, 
may lead to premature cessation of therapy [5,6], 
studies have also found that information from 
DPI may be useful in increasing patient’s 
knowledge, compliance, and satisfaction [6]. 
However, despite the high proportion of 
respondents who rely on DPI as a source of drug 
information; many believed that there is need for 
improvement in the content of DPI especially in 
the areas of non-uniformity of information on the 
same generic medicines, clarity of contents, and 
improvement of both the patient- and healthcare 
professional-related information. This finding 
corroborated earlier studies by Al-Aqeel and 
Sawalha et al [8,9].  
 
Improvement on DPI typography will improve 
legibility allowing for easy comprehension and 
understanding by lay patients, as well as 
preventing confusion and misinformation. These 
suggested modifications become necessary in 
order to make DPI a reliable source of drug 
information in daily community pharmacist 
practice, as well as ensuring an informed self-
management decision by patients. This is 
especially important in Nigeria, where 
prescription-only medicines could easily be 
obtained without prescriptions, thereby making 
patients prone to misinterpretation or 
misunderstanding of the information in the drug 
package inserts. This study is limited by the fact 
that it did not differentiate between the DPI for 





Community pharmacists in southwestern Nigeria 
believe that a drug package insert that has been 
properly modified for clarity of content and 
contains pertinent, important and uniform 
information will be a useful and reliable source of 
drug information that may be helpful in achieving 
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